| Popis: |
Background: Previously, we observed that adiponectin—an adipose tissue-derived hormone—was negatively correlated with muscle strength while myostatin—a myokine protein secreted by skeletal muscle—was positively correlated with appendicular lean mass. Albeit interesting, the relevance of these relationships is unclear. Thus, we aimed to examine the relationship between myostatin, adiponectin, and body composition in patients with obesity undergoing a weight loss program.Methods: We studied 66 patients with obesity (age: 46.8 ± 14.0 years, body mass index: 34.3 [31.0, 38.4] kg/m2) attending a hospital for a weight loss program. Participants were divided into those with weight reduction less than 5% (the L group) and greater than 5% (the M group) from the baseline. All patients underwent blood tests and were assessed for body composition, insulin resistance, adipocytokines, myokines, exercise tolerance, and muscle strength at baseline and after the program. Results: Serum myostatin and adiponectin levels increased after the program in both groups. Body weight and %fat decreased, and the rate of lean body mass (%LBM) increased in both groups. Exercise capacity and muscle strength improved in the M group only. Change in (⊿) myostatin correlated with ⊿%fat, ⊿%LBM, and ⊿adiponectin. ⊿adiponectin (β = -0.262, p = 0.035) as an independent predictor of ⊿myostatin. Conclusions: Myostatin and adiponectin might crosstalk and regulate changes in skeletal muscle and fat mass. These findings might predict the effects of weight loss and prevent skeletal muscle mass loss by evaluating serum myostatin and adiponectin in clinical practice. |
